Company: SHPH
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022162
Chunk: 9

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part II, Item 1
Chunk 9
---

herewith.

35

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

    SHUTTLE
    PHARMACEUTICALS HOLDINGS, INC.

    November
    13, 2025
    By:
    /s/
    Christopher Cooper

    Christopher
    Cooper

    Interim
    Chief Executive Officer

    (Principal
    Executive Officer)

    November
    13, 2025
    By:
    /s/
    Timothy J. Lorber

    Timothy
    J. Lorber
    Chief
    Financial Officer

    (Principal
    Financial and Accounting Officer)

36